← Back to CORE30
COMPANY RESEARCH

ABT

ABT · CORE30 Company
CORE30 Rank #22
OVERALL SCORE73.7Rank #22 · Out of 100

Company research profile within the AtechFuture CORE30 universe.

QUALITY60.0

Capital efficiency, operating profitability and free cash flow.

GROWTH66.7

Revenue, EBITDA and free cash flow growth.

MOAT90.0

Network, customer lock-in and structural advantages.

01 / FINANCIAL FUNDAMENTALS

Financial Fundamentals

QUALITY · 60.0 / 100

ROIC

7.5%

Operating Margin

17.1%

FCF Margin

16.3%
QUALITY & GROWTH

Growth Performance

GROWTH · 66.7 / 100

Revenue CAGR 3Y

5.0%

EBITDA CAGR 3Y

7.8%

FCF CAGR 3Y

12.5%
02 / COMPETITIVE ADVANTAGES

Competitive Advantages

MOAT SUMMARY

Abbott has built a diversified healthcare moat through clinical evidence, product reliability, and medical distribution channels across medical devices, diagnostics, and nutrition products. Key factors to watch include Libre growth, medical device innovation, recovery in diagnostics, and profitability across its business segments.

MOAT SCORE · 90.0 / 100

Network & Ecosystem

88.0 / 100

Customer & Technology Lock-in

91.0 / 100

Structural Advantage

91.0 / 100
03 / RESEARCH TIMELINE

Research Timeline

Material Business Events

No material business events recorded.

Research Conclusion Changes

No material research conclusion changes recorded.